In this study, MSC cells from bone marrow and cord tissue were cultured in identical conditions. Comparative tests for certain measures were run at 0, 3, and 6 weeks.26 The hUC-MSCs were better able to produce collagen — nearly 3x as much collagen production as hBMSCs — and had faster proliferation which provides a larger number of cells in a shorter period of time.
Based on the results researchers concluded that hUC-MSCs may be a desirable option for use as a MSC cell source for a particular type of tissue engineering called fibrocartilage tissue engineering — used in such areas as the knee (meniscus) or the jaw joint (temporomandibular joint, TMJ). They also noted that with further investigation hUC-MSCs may have the potential to surpass the standard source hB-MCS in other types of cartilage regeneration.